{"id":494,"date":"2018-09-19T09:35:46","date_gmt":"2018-09-19T09:35:46","guid":{"rendered":"http:\/\/www.farmacovigilanciacanarias.org\/noticias\/?p=494"},"modified":"2018-09-19T09:35:46","modified_gmt":"2018-09-19T09:35:46","slug":"retinoides-actualizacion-de-los-efectos-teratogenicos-y-trastornos-neuropsiquiatricos","status":"publish","type":"post","link":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/2018\/09\/19\/retinoides-actualizacion-de-los-efectos-teratogenicos-y-trastornos-neuropsiquiatricos\/","title":{"rendered":"Retinoides : Actualizaci\u00f3n de los efectos teratog\u00e9nicos y trastornos neuropsiqui\u00e1tricos"},"content":{"rendered":"<p><a id=\"gvwDocumentos_ctl02_hlkEnlace\" href=\"https:\/\/sinaem.agemed.es\/CartasFarmacovigilanciaDoc\/2018\/Retinoides_DHPC-19-septiembre-2018.pdf\" target=\"_blank\" rel=\"noopener\">ACTUALIZACI\u00d3N DE LOS EFECTOS TERATOG\u00c9NICOS Y TRASTORNOS NEUROPSIQUI\u00c1TRICOS<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ACTUALIZACI\u00d3N DE LOS EFECTOS TERATOG\u00c9NICOS Y TRASTORNOS NEUROPSIQUI\u00c1TRICOS<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-494","post","type-post","status-publish","format-standard","hentry","category-seguridad"],"_links":{"self":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/494","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/comments?post=494"}],"version-history":[{"count":1,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/494\/revisions"}],"predecessor-version":[{"id":495,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/494\/revisions\/495"}],"wp:attachment":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/media?parent=494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/categories?post=494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/tags?post=494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}